Download the Prospectus
Pre Money Equity Valuation
$38,500,000
Min Raise
$10,150,000
Max Raise
$10,150,000
Estimated Close
2018-10-12
Issue Type
IPO
Lead Manager
RM Corporate Finance Pty Ltd
Type of Securities
Shares
Date First Lodged
20/08/2018
Offer Costs $
$1,600,000
Market Cap Max
$48,650,000
Key Executives
Dave Sharma (NEC), Yoram Porat (ED and CEO), Isaac Raviv (NED), Beth Kaplan (NED), Tzipi Avioz (NED), Sophie Raven (NED)
Company Address
Level 3, 50 Holt Street, Surry Hills NSW 2010
Stockbroker's Snapshot
High tech scale manufacturer
Exchange
ASX
Chairman's Letter

Dear Investor,
On behalf of the Directors, I am pleased to present this Prospectus and to offer you the opportunity to become an investor
in Shekel Brainweigh Ltd (“Shekel Brainweigh” or the “Company”), the holding company of a long established Israeli group
(“Group”) at the forefront of the electronic weighing industry.
With this Prospectus, the Company is inviting investors to subscribe for fully paid ordinary shares (Shares), at an Offer Price of
AU$0.35 to raise AU$10,150,000 (before costs and expenses).
The Group has been developing, manufacturing and distributing advanced weighing technology solutions for the retail,
healthcare and manufacturing markets for over 40 years. It was an early participant in the development of digital scaling in the
1970s, and provides precision weighing solutions to customers including Toshiba, Fujitsu, Datalogic, Diebold-Nixdorf and
GE Healthcare.
While the Group has a track record of revenue and profitability from its existing operations, it is also developing new weighing
technologies. The Group’s innovations in this area have led to the development of its Product Aware Surface Technology, an
integral part of the Retail Solutions Suite which the Company proposes to offer to this sector.
Traditional retail faces three significant challenges today, namely, store automation, operational efficiency and enhancing
consumer experience as described in further detail in this Prospectus. The Directors believe that the combination of favourable
growth characteristics of the key retail and healthcare markets in which the Group operates, on the one hand, and the Company’s
development and commercialisation of its Retail Solutions Suite, on the other hand, will support the Company’s strategic plans in
each of those markets.
The proceeds of the Offer will enable further research and development in this area and in addition to earnings from its core
business, provide Shekel Brainweigh with the working capital required for the proposed global deployment of its Retail Solutions
Suite. The Company may also undertake acquisitions of complementary products or businesses should appropriate opportunities
arise, as it has done in the past.
The Company is incorporated under the laws of Israel and there are a number of differences between those laws and the laws of
Australia, as described in further detail in this Prospectus. The Prospectus also provides an overview of potential risks associated
with investing in Shekel Brainweigh, including, among others, risks inherent to the Group’s key intellectual property assets,
manufacturing and production, competition and new technology.
This Prospectus includes full details of the Offer and the Company. The Offer is being Lead Managed by RM Corporate Finance
Pty Ltd (AFSL 315235).
I urge you to read this Prospectus carefully and seek professional advice to determine whether this investment is appropriate
for you.
On behalf of the Directors of Shekel Brainweigh, I invite you to take part in this exciting investment opportunity. I look forward to
the continuing support of our existing shareholders and welcoming new investors to the Company.
Yours faithfully
Dave Sharma
Chairman
Shekel Brainweigh Ltd